Received letters today from CVS. It seems our coverage is changing and, effective January 1st, 2020, we are no longer going to be covered for Lantus; instead, we’re being switched to Levemir. I have read some older threads on Levemir and I don’t think it’ll be an issue. Currently, we don’t even use the Lantus we receive anyway since we use Novolog in his PODs…the Lantus is just back up and we have a ton stored currently.
The transition that’s bothering me more is that it seems our Contour Next one and test strips are also no longer going to be covered. We are being requested to switch to Accu check meter/strips. The letter indicates we can request authorization from the Endo to continue using the Contour system and, if authorized/approved by the insurance, it could be covered.
My question is - do you think any reasons I submit would be enough to have it approved? If not, I won’t even waste my time putting in the request. My reasons that I like the contour next one included:
- Small and compact
- Liam is able to use it to check his own bgs because it’s small enough that he can hold it.
- It doesn’t add a lot of extra weight to his diabetes pack he carries with him
- Requires a small amount of blood
- Most accurate meter on the market
In your opinions, would any of these reasons convince an insurance to continue being authorized to use it?
Which accu check meter do you think is the best (considerations that are most important to me include accuracy, size, smallest blood drop possible).